|
METTL13 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.224050E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.76950000000087E-05 |
| Normal-vs-Stage2 |
1.196380E-01 |
| Normal-vs-Stage3 |
5.904200E-01 |
| Normal-vs-Stage4 |
3.746000E-01 |
| Stage1-vs-Stage2 |
7.333000E-01 |
| Stage1-vs-Stage3 |
7.214200E-02 |
| Stage1-vs-Stage4 |
6.897800E-01 |
| Stage2-vs-Stage3 |
1.674980E-01 |
| Stage2-vs-Stage4 |
9.063400E-01 |
| Stage3-vs-Stage4 |
3.845400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.090400E-02 |
| Normal-vs-AfricanAmerican |
1.496670E-03 |
| Normal-vs-Asian |
3.932800E-01 |
| Caucasian-vs-AfricanAmerican |
1.293440E-01 |
| Caucasian-vs-Asian |
5.916400E-01 |
| AfricanAmerican-vs-Asian |
8.788200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.982200E-04 |
| Normal-vs-Female |
5.509600E-01 |
| Male-vs-Female |
2.275500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.754190E-01 |
| Normal-vs-Extreme_Weight |
2.2674999999972E-05 |
| Normal-vs-Obese |
1.772790E-01 |
| Normal-vs-Extreme_Obese |
9.496200E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.403400E-01 |
| Normal_Weight-vs-Obese |
7.139200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.713400E-01 |
| Extreme_Weight-vs-Obese |
3.500500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.631000E-01 |
| Obese-vs-Extreme_Obese |
2.530800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.410400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.143600E-02 |
| Normal-vs-Age(61-80Yrs) |
2.748200E-02 |
| Normal-vs-Age(81-100Yrs) |
3.353100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.783360E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.602010E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.303000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.794200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.798300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.195100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.357400E-03 |
| Normal-VS-Type2 PRCC |
2.923600E-01 |
| Normal-VS-KIRP CIMP |
8.161600E-01 |
| Normal-VS-Unclassified PRCC |
7.237400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.037800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.532600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.204000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.434800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.667800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.959800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.589950E-02 |
| Normal-vs-N1 |
2.187400E-01 |
| Normal-vs-N2 |
5.786200E-01 |
| N0-vs-N1 |
3.592300E-02 |
| N0-vs-N2 |
8.253600E-01 |
| N1-vs-N2 |
4.264600E-01 |
|
|
